Matches in Nanopublications for { ?s ?p "[PBMC pretreatment with IL-2 allowed reaching 65 � 3% of Cetuximab-mediated ADCC against IIB-BR-G and 63 � 6.5% against IIB-BR-G MT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP580908.RA9qnNw2F5RSMHYH0fL3rGycHbRaVEvT3GIzVreGfF5HM130_assertion description "[PBMC pretreatment with IL-2 allowed reaching 65 � 3% of Cetuximab-mediated ADCC against IIB-BR-G and 63 � 6.5% against IIB-BR-G MT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580908.RA9qnNw2F5RSMHYH0fL3rGycHbRaVEvT3GIzVreGfF5HM130_provenance.